Iron oxide nanoparticles improved biocompatibility and removal of middle molecule uremic toxin of polysulfone hollow fiber membranes
Middle molecule uremic toxins constitute to a quarter of uremic toxins present in human blood. In a condition where these uremic toxins accumulate in bloodstream due to renal failure, blood purification process using a high performance membrane is required. Here, we develop biocompatible mixed matri...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
John Wiley and Sons Inc.
2019
|
| Subjects: |